ELCC Updates in Immunotherapy and Beyond for Non–Small Cell Lung Cancer - Episode 3

CTLA-4 Targeted Regimens in Advanced NSCLC

, ,

Solange Peters, MD, PhD, detail the subgroups of patients with advanced NSCLC and how treatment varies.

Sponsored in part by Regeneron. Content independently created by OncLive.